StatSure Diagnostic Systems Inc (SSUR)

Stat-Sure is a biotechnology company established in 1986 that has carved a niche for itself in the healthcare industry with its rapid, user-friendly diagnostic tests. The company's slogan "Rapid, user-friendly diagnostic tests for quick HIV detection, fueling impressive growth in healthcare markets," aptly captures its mission. Specializing in Point-of-Care (POC) diagnostic tests for the detection of HIV 1/2, particularly its SURE CHECK HIV 1/2 and Clearview Complete HIV 1/2 tests, StatSure Diagnostic Systems, Inc. has made significant strides in providing simple, single-use diagnostic tools that swiftly and visually identify antibodies to HIV 1 and HIV 2. These tests, manufactured in the United States by Chembio Diagnostics and distributed by Alere under the brand name Complete HIV 1/2, have garnered widespread adoption in clinics, hospitals, and physician practices across the United States, thereby contributing to a substantial surge in the company's annual sales. Through its innovative product offerings, Stat-Sure is well-positioned to tap into the burgeoning healthcare markets. With a focused approach on advancing HIV diagnostic technology, the company has demonstrated its commitment to addressing critical healthcare needs. As the company continues to evolve and expand its footprint, potential investors in the biotechnology and healthcare sectors should keep a keen eye on Stat-Sure as it navigates towards further growth and development.